Several breakthroughs in recent years have rapidly shifted the treatment landscape for advanced HCC.
Timothy J. Brown, MD
Advertisement
Articles by Timothy J. Brown, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Sevabertinib for Advanced HER2 TKD–Mutated Nonsquamous NSCLC
2
Durvalumab Plus Tarlatamab Boosts Survival as First-Line ES-SCLC Maintenance
3
Camidge and Singhi Highlight the Lung Cancer Abstracts to Watch at WCLC 2026
4
Frontline Mipletamig Triplet Drives Clinical Benefit in TP53-Mutated AML
5